SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Teva Pharmaceuticals
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
339 21 0 TEVA
Emcee:  Prasanna L Soni Type:  Unmoderated
Great company. Has a drug for Multiple Sclerosis .Some important DATA comming out in october,I believe Phase III clinicals.Looks good technically. Any followers any interest? A G Edwards has a 12 month target of $60.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
339Tone of the company seems to have changed to positive rather than defensive. AnLance Bredvold-February 27
338Sold at $9.40 but when the price did not immediately drop, bought back even moreLance Bredvold-January 9
337So no sooner do I say I won't be buying any more than I begin buying more. Lance Bredvold-8/2/2023
336Thinking a bit more about the legal problem TEVA faces with opioid settlements. Lance Bredvold112/6/2022
335Just read through the CEO and CFO earnings conference call and am mildly positivLance Bredvold-11/11/2022
334I was just reading a review of the drug companies which are showing excellent prLance Bredvold111/5/2022
333Thank you for the perspective.RonBerk-11/5/2022
332I watched something similar for RPM with asbestos liability suits. For many yeaLance Bredvold111/1/2022
331It seems every time a settlement is announced the Teva stock goes up.RonBerk-10/30/2022
330Have concerns over potential opioid damages faded?Lance Bredvold-10/8/2021
329I want to get some feedback Teva Pharmaceuticals. I know they've had issues Adam H-10/1/2021
328TEVA 22.57+2.59 (+12.96%) 1:26PM EDT Israel's Teva gives upbeat outlook aszax-11/1/2018
327Berkshire Hathaway Increased Its Stake in Teva Again On August 14, Warren Buffezax-8/20/2018
326Now, it goes up on high volume, drops on low volume. Clearly bullish sign. Worstmore100-2/23/2017
325TEVA is not just generics. In 3Q16, TEVA derived 42%(!) of its worldwide operatiDewDiligence_on_SI-1/16/2017
324This is the go to company for generics - isn't this what the new healthcare more100-1/16/2017
323Israel named ‘developed’ market: siliconinvestor.comDewDiligence_on_SI-6/15/2009
322Time to look seriously at Teva again?LLLefty-2/15/2007
321Analysts enthuse over Teva results. William Blair, Deutsche Bank, Hambrecht and midastouch017-3/2/2006
320Teva CEO quits Hapoalim board Israel Makov is resigning to devote more time tomidastouch017-2/21/2006
319Teva will report $1.44 billion Q4 revenues, predicts Clal Finance 20.2.06 | 18midastouch017-2/21/2006
318<b>Teva’s Makov: We’re already looking at 2020 Israel Makov explained tomidastouch017-12/4/2005
317Teva Announces Final Approval of Buspirone Tablets February 28, 2002 1:46:00 PM Dorine Essey-2/28/2002
316Thanks for the heads up. Still holding core position. Both eyes on Mid East.flatsville-2/12/2002
315Nessuah Zannex: Further Teva acquisition in pipeline Globes' corespondent 1Dorine Essey-2/12/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):